Company Profile Built to break barriers: How Grove Biopharma is architecting its way around traditional drug limits By Dr. Emily Park, Dr. Kiersten Stead
Company Profile Elo’s breakthrough science offers scalable, domestic solutions to replacing sugar and artificial sweeteners By Dr. Justin Kern
Thoughts Professor Prineha Narang joins DCVC as we double down on our historical quantum tech leadership By Matthew Ocko, Zachary Bogue
Deep Tech Opportunities Report DCVC publishes the 2025 Deep Tech Opportunities Report: “An American Industrial Renaissance” By Matthew Ocko, Zachary Bogue
Deep Tech Opportunities Report DCVC DTOR 2024: Startup thinking will help the defense and security sectors prepare for new threats
News Latus Bio finds a better way to deliver genes to cells deep in the brain to help patients with neurodegeneration By Dr. Kiersten Stead
News Creyon Bio deal with Lilly brings up to $1 billion in payments for research on RNA-targeting drugs By Dr. Kiersten Stead
Snapshot Kanvas Bio speeds the search for microbiome therapies through industrial-scale imaging of gut and host cells By Jason Pontin
News Quantum Advantage: Q-CTRL’s next-generation navigation system to guide us when GPS can’t By James Hardiman
Deep Tech Opportunities Report DCVC DTOR 2024: Industry is turning to unconventional water sources for fresh water and critical minerals
News Lumafield raises $75 million to give manufacturers a look deep inside their products as they come out of the lab and off the line By James Hardiman
Deep Tech Opportunities Report DCVC DTOR 2024: Drop-in replacements are a way to start decarbonizing the economy, now
Deep Tech Opportunities Report DCVC DTOR 2024: New storage and generation technologies will make the electrical grid cleaner and more resilient
News CH4 Global opens the world's first commercial-scale Asparagopsis production facility By Zachary Bogue, Dr. Justin Kern
Deep Tech Opportunities Report DCVC DTOR 2024: TechBio is emerging as the data-centric, AI-native counterweight to biotech
Deep Tech Opportunities Report DCVC DTOR 2024: Artificial general intelligence can be as distracting as it is alluring
News Alta debuts with $5.1 million Seed to sustainably separate critical minerals using advanced biochemistry By James Hardiman
News Relation Therapeutics partners with GSK in history-making collaboration to create new treatments for fibrosis and osteoarthritis By Jason Pontin
Deep Tech Opportunities Report DCVC DTOR 2024: With quantum computing, we invest in the picks and shovels
News Radiant Industries raises $100 million DCVC Climate–led Series C to speed microreactors to market By Dr. Rachel Slaybaugh
Thoughts Climate tech’s lemons-to-lemonade moment: how the private sector can ensure a durable, clean American industrial renaissance By Milo Werner
Deep Tech Opportunities Report DCVC DTOR 2024: Agility Robotics is a real-world case study in operational data
Deep Tech Opportunities Report DCVC DTOR 2024: In the AI race, data will emerge as the critical asset
Deep Tech Opportunities Report DCVC DTOR 2024: A few words on the investing climate By Matthew Ocko, Zachary Bogue